Osteoporotic Vertebral Fracture — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Alendronate (oral bisphosphonate)
Osteoporotic fracture with T-score ≤-2.5 requires pharmacological treatment beyond calcium/vitamin D. Oral bisphosphonates (alendronate or risedronate) are first-line for osteoporosis. They reduce vertebral and non-vertebral fracture risk by 40–50%. For very high fracture risk (multiple fractures, T-score <-3.5), anabolic agents (teriparatide, romosozumab) may be considered as initial therapy.
Reference: RACGP/Osteoporosis Australia – 2024 – Osteoporosis Guidelines; ANZBMS